跳至主要内容
临床试验/CTRI/2009/091/001041
CTRI/2009/091/001041已完成3 期

?A CONTROLED LABELED, DOUBLE ARM, RANDOMIZED, MULTI- CENTRIC, PROSPECTIVE PHASE III CLINICAL TRIAL TO COMPARE EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF DOXOPHYLLINE 800 mg SR AND MONTELUKAST 10 mg WITH DOXOPHYLLINE 800mg SR IN SUBJECTS SUFFERING WITH ACUTE BRONCHOSPASM OF DIFFERENT ETIOLOGY?

Swiss Garnier Life SciencesNo. 68A, Vembuli Amman koli St, Alandur, Chennai 600016 .Phone : 044-22329837, 223128920 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Patients of either sex of age >= 18 and <= 70 years.
  • •Patient suffering from mild to moderate bronchospasm of different etiology.
  • •PEF between 50% to 80 % (mild to moderate)by using Peak flow meter.
  • •Pre menopausal women must use the appropriate contraception.
  • •Patient willing to give informed consent.

排除标准

  • •Patients with significant pulmonary insufficiency, including both intrinsic lung disease and Respiratory failure i.e. severe bronchospasm
  • •Patient with a history of known hypersensitivity from any one of the said medication.
  • •Patients with acute myocardial infarction, hypotension.
  • •Patients with uncontrolled hypertension.
  • •Bronchospasm of anaphylactic, mechanical or cancerous origin.
  • •Subjects with severe hepatic, renal failure or encephalopathy.
  • •Chronic alcoholics.
  • •Patients with history of cardiac surgery.
  • •Pregnant & lactating women.

研究者

发起方
Swiss Garnier Life SciencesNo. 68A, Vembuli Amman koli St, Alandur, Chennai 600016 .Phone : 044-22329837, 22312892

相似试验

尚未招募
2 期
A CLINICAL TRIAL TO STUDY THE EFFECT OF PATHADI CHURNA IN FUNGAL INFECTION OF SKI
CTRI/2021/01/030238Dean Faculty of Ayurved Parul University
已完成
3 期
A clinical trial to study the effects of two drugs,metformin and Alpha Lipoic Acid combination in patients of Diabetic polyneuropathy.
CTRI/2009/091/000714M/S JENBURKT PHARMACEUTICALS LTD.200
已完成
3 期
A CLINICAL TRIAL TO STUDY THE EFFECTS OF FIXED-DOSE COMBINATION OF PARACETAMOL 500MG AND PAMABROM 25mg WITH PARACETAMOL ALONE IN THE TREATMENT OF PATIENTS WITH PREMENSTRUAL SYNDROME
CTRI/2010/091/001274Akums Drugs &amp; Pharmaceuticals Limited ., Delhi200
进行中(未招募)
不适用
A RANDOMIZED, DOUBLE BLIND, TWO ARM, PARALLEL, PLACEBO CONTROLLED STUDY OF RIMONABANT 20MG EFFECT ON HIGH DENSITY LIPOPROTEIN KINETICS IN PATIENTS WITH ABDOMINAL OBESITY AND ADDITIONAL CARDIOMETABOLIC RISK FACTORS - HDL TURNOVERPATIENTS WITH ABDOMINAL OBESITY AND ADDITIONAL CARDIOMETABOLIC RISK FACTORSMedDRA version: 8.1Level: LLTClassification code 10059179Term: Abdominal obesity
EUCTR2006-001716-71-GBsanofi aventis Groupe80
进行中(未招募)
不适用
A RANDOMIZED, DOUBLE BLIND, TWO ARM, PARALLEL, PLACEBO CONTROLLED STUDY OF RIMONABANT 20MG EFFECT ON HIGH DENSITY LIPOPROTEIN KINETICS IN PATIENTS WITH ABDOMINAL OBESITY AND ADDITIONAL CARDIOMETABOLIC RISK FACTORS - HDL TURNOVERPATIENTS WITH ABDOMINAL OBESITY AND ADDITIONAL CARDIOMETABOLIC RISK FACTORSMedDRA version: 8.1Level: LLTClassification code 10059179Term: Abdominal obesity
EUCTR2006-001716-71-FIsanofi aventis Groupe80